17DD and 17D-213/77 Yellow Fever Substrains Trigger a Balanced Cytokine Profile in Primary Vaccinated Children

被引:23
作者
Campi-Azevedo, Ana Carolina [1 ]
de Araujo-Porto, Luiza Pacheco [1 ]
Luiza-Silva, Maria [1 ]
Batista, Mauricio Azevedo [2 ]
Martins, Marina Angela [1 ]
Sathler-Avelar, Renato [1 ]
da Silveira-Lemos, Denise [2 ]
Bastos Camacho, Luiz Antonio [3 ]
Martins, Reinaldo de Menezes [4 ]
de Sousa Maia, Maria de Lourdes [4 ]
Guedes Farias, Roberto Henrique [4 ]
Freire, Marcos da Silva [4 ]
Galler, Ricardo [4 ]
Homma, Akira [4 ]
Leite Ribeiro, Jose Geraldo [5 ]
Campos Lemos, Jandira Aparecida [5 ]
Auxiliadora-Martins, Maria [6 ]
Caldas, Iramaya Rodrigues [7 ]
Eloi-Santos, Silvana Maria [8 ]
Teixeira-Carvalho, Andrea [1 ]
Martins-Filho, Olindo Assis [1 ]
机构
[1] Fiocruz MS, Lab Biomarcadores Diagnost & Monitoraco, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil
[2] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil
[3] Fiocruz MS, Escola Nacl Sau Publ, BR-21045900 Rio De Janeiro, Brazil
[4] Fiocruz MS, Inst Tecnol Imunobiol, BR-21045900 Rio De Janeiro, Brazil
[5] Governo Estado Minas Gerais, Secretaria Estado Saude, Belo Horizonte, MG, Brazil
[6] Univ Sa Paulo USP, Hosp Clin, Fac Med Ribeirao Preto, Sao Paulo, Brazil
[7] Fiocruz MS, Diretoria Reg Brasilia, Brasilia, DF, Brazil
[8] Univ Fed Minas Gerais, Dept Propedeut Complementar, Fac Med, Belo Horizonte, MG, Brazil
关键词
DOUBLE-BLIND; NEUTRALIZING ANTIBODY; PHASE-III; IMMUNOGENICITY; IMMUNITY; TRIAL; IMMUNIZATION; INFANTS; MEASLES; INNATE;
D O I
10.1371/journal.pone.0049828
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Background: This study aimed to compare the cytokine-mediated immune response in children submitted to primary vaccination with the YF-17D-213/77 or YF-17DD yellow fever (YF) substrains. Methods: A non-probabilistic sample of eighty healthy primary vaccinated (PV) children was selected on the basis of their previously known humoral immune response to the YF vaccines. The selected children were categorized according to their YF-neutralizing antibody titers (PRNT) and referred to as seroconverters (PV-PRNT+) or nonseroconverters (PV-PRNT-). Following revaccination with the YF-17DD, the PV-PRNT- children (YF-17D-213/77 and YF-17DD groups) seroconverted and were referred as RV-PRNT+. The cytokine-mediated immune response was investigated after short-term in vitro cultures of whole blood samples. The results are expressed as frequency of high cytokine producers, taking the global median of the cytokine index (YF-Ag/control) as the cut-off. Results: The YF-17D-213/77 and the YF-17DD substrains triggered a balanced overall inflammatory/regulatory cytokine pattern in PV-PRNT+, with a slight predominance of IL-12 in YF-17DD vaccinees and a modest prevalence of IL-10 in YF-17D-213/77. Prominent frequency of neutrophil-derived TNF-alpha and neutrophils and monocyte-producing IL-12 were the major features of PV-PRNT+ in the YF-17DD, whereas relevant inflammatory response, mediated by IL-12(+)CD8(+) T cells, was the hallmark of the YF-17D-213/77 vaccinees. Both substrains were able to elicit particular but relevant inflammatory events, regardless of the anti-YF PRNT antibody levels. PV-PRNT 2 children belonging to the YF-17DD arm presented gaps in the inflammatory cytokine signature, especially in terms of the innate immunity, whereas in the YF-17D-213/77 arm the most relevant gap was the deficiency of IL-12-producing CD8(+)T cells. Revaccination with YF-17DD prompted a balanced cytokine profile in YF-17DD nonresponders and a robust inflammatory profile in YF-17D-213/77 nonresponders. Conclusion: Our findings demonstrated that, just like the YF-17DD reference vaccine, the YF-17D-213/77 seed lot induced a mixed pattern of inflammatory and regulatory cytokines, supporting its universal use for immunization.
引用
收藏
页数:12
相关论文
共 35 条
[1]
Learning vaccinology from viral infections [J].
Ahmed, Rafi ;
Pulendran, Bali .
JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (12) :2347-2349
[2]
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response [J].
Akondy, Rama S. ;
Monson, Nathan D. ;
Miller, Joseph D. ;
Edupuganti, Srilatha ;
Teuwen, Dirk ;
Wu, Hong ;
Quyyumi, Farah ;
Garg, Seema ;
Altman, John D. ;
Del Rio, Carlos ;
Keyserling, Harry L. ;
Ploss, Alexander ;
Rice, Charles M. ;
Orenstein, Walter A. ;
Mulligan, Mark J. ;
Ahmed, Rafi .
JOURNAL OF IMMUNOLOGY, 2009, 183 (12) :7919-7930
[3]
Immune response during adverse events after 17D-derived yellow fever vaccination in Europe [J].
Bae, Hi-Gung ;
Domingo, Cristina ;
Tenorio, Antonio ;
de Ory, Fernando ;
Munoz, Jose ;
Weber, Paul ;
Teuwen, Dirk E. ;
Niedrig, Matthias .
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (11) :1577-1584
[4]
Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: Implications for the Brazilian National Immunization Program [J].
Bastos Camacho, Luiz Antonio ;
da Silva Freire, Marcos ;
da Luz Fernandes Leal, Maria ;
Souza Maia, Maria De Lourdes ;
Martins, Reinaldo Menezes ;
Yamamoto Yoshida, Anna Maia ;
Sato, Helena Keico ;
Fernandes, Guilherme Cortes ;
Perez de Castro, Ivone ;
Lemos, Jandira Campos ;
Barros, Eugenio Martins ;
Igushi, Takumi ;
Leitdo, Marcia Borges ;
Batista, Maristela ;
da Conceicao Barros, Maria ;
Sao Paulo, Elisabete Paganini ;
Nascimento, Marileide ;
da Silva, Nilce ;
Baran, Meri ;
Pernambuco, Eduardo ;
Leal Costa, Antonio Jose .
VACCINE, 2007, 25 (16) :3118-3123
[5]
Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (ARILVAX™ and YF-VAX®) in healthy infants and children in Peru [J].
Belmusto-Worn, VE ;
Sanchez, JL ;
McCarthy, K ;
Nichols, R ;
Bautista, CT ;
Magill, AJ ;
Pastor-Cauna, G ;
Echevarria, C ;
Laguna-Torres, VA ;
Samame, BK ;
Baldeon, ME ;
Burans, JP ;
Olson, JG ;
Bedford, P ;
Kitchener, S ;
Monath, TP .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 72 (02) :189-197
[6]
Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial [J].
Camacho, LAB ;
de Aguiar, SG ;
Freire, MD ;
Leal, MDF ;
Do Nascimento, JP ;
Iguchi, T ;
Lozana, JA ;
Farias, RHG .
REVISTA DE SAUDE PUBLICA, 2005, 39 (03) :413-420
[7]
Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial [J].
Camacho, LAB ;
Freire, MD ;
Leal, MDL ;
de Aguiar, SG ;
do Nascimento, JP ;
Iguchi, T ;
Lozana, JD ;
Farias, RHG .
REVISTA DE SAUDE PUBLICA, 2004, 38 (05) :671-678
[8]
Centers for Disease Control and Prevention, 2011, NEWS YELL FEV BRAZ C
[9]
TLR expression and NK cell activation after human yellow fever vaccination [J].
da Costa Neves, Patricia Cristina ;
de Souza Matos, Denise Cristina ;
Marcovistz, Rugimar ;
Galler, Ricardo .
VACCINE, 2009, 27 (41) :5543-5549
[10]
Fleiss J. L., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923, DOI 10.1002/9781118032923]